Breast MRI may help determine surgical management of women with newly diagnosed breast cancerMay 22, 2007Among women who are newly diagnosed with breast cancer, magnetic resonance imaging (MRI) of the breast appears helpful in determining surgical treatment, according to a report in the May issue of Archives of Surgery, one of the JAMA/Archives journals. Women who have been newly diagnosed with breast cancer are at risk of having another, hidden tumor in the same or opposite breast, according to background information in the article. If these additional tumors are detected before surgery to remove the initially diagnosed tumor, the plan for surgical management of the disease can be altered. For instance, if additional cancer is found in the same breast, a surgeon can perform a mastectomy (removal of the whole breast) instead of a lumpectomy (removal of a part of the breast) or remove a larger amount of tissue during a lumpectomy. If cancer is detected in the other breast, surgery can be done on both breasts at once. "However, the impact of routine MRI on the surgical management of new, biopsy-proven breast cancers remains unclear," the authors write. Karl Y. Bilimoria, M.D., and colleagues at the Feinberg School of Medicine, Northwestern University, Chicago, assessed 155 women with breast cancer newly diagnosed by mammogram, ultrasound and needle biopsy (testing of a small amount of tissue). The women, who were diagnosed between April 2005 and April 2006, went to a single surgeon who performed an evaluation and developed a plan for the surgical management of the disease. After this consultation, MRI was performed on both breasts. If the MRI detected new tumors that were found to be malignant or suspicious after a biopsy, patients went back to the surgeon for a re-evaluation of the surgical plan. Breast MRI detected a total of 124 additional suspicious areas in 73 patients. "Breast MRI altered the surgical management of patients with newly diagnosed breast cancer in 36 (23.2 percent) of 155 patients," the authors write. This included 10 patients who had a mastectomy instead of lumpectomy, 21 women whose lumpectomy removed more tissue than originally planned, and five patients who had surgery on both breasts. Following surgery, the researchers compared the actual appearance of the cancer to the original mammogram or ultrasound and also to the MRI. The change in surgical management was considered beneficial if pathological findings matched the MRI more closely than they matched mammography or ultrasonography. "Of the 36 women who had a change in surgical management based on MRI findings, 15 were found to have a beneficial change when MRI findings were confirmed on the final pathologic report," the authors write. The change was determined to be beneficial in eight women whose lumpectomy was converted to a mastectomy, 10 patients who received a larger lumpectomy and two patients who had surgery on both breasts. "Additional malignancies are uncovered in one patient for every 10 who undergo MRI," the authors conclude. "These data suggest that breast MRI may have a role in the staging evaluation of newly diagnosed breast cancers." JAMA and Archives Journals |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||